Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Haimeng Tang
Observed name:
H. Tang
Institutions:
University of Science and Technology of China,
Second People Hospital of Hunan
Observed institutions:
University of Science and Technology of China,
Nanjing University of Science and Technology,
Second People Hospital of Hunan
ORCID:
0000-0002-7519-8213
Observed ORCID:
0000-0002-7519-8213
OpenAlex ID:
A5109043926
Exploring potential molecular resistance and clonal evolution in advanced HER2-positive gastric cancer under trastuzumab therapy
2023
·
Qi Xu
, Xiaoqing Xu
, et al.
·
Oncogenesis
·
26
PDF
Testing the generalizability of cfDNA fragmentomic features across different studies for cancer early detection
2023
·
Shu Su
, Yulong Xuan
, et al.
·
Genomics
·
8
Mutational landscape of SWI/SNF complex genes reveal correlation to predictive biomarkers for immunotherapy sensitivity in lung adenocarcinoma patients
2023
·
H. Xu
, H.-C. Chen
, et al.
·
ESMO Open
·
7
PDF
Comprehensive profiling of pathogenic germline large genomic rearrangements in a pan‐cancer analysis
2023
·
Zhe Sun
, Chujie Bai
, et al.
·
Molecular Oncology
·
6
PDF
Cell-free DNA assay for malignancy classification of high-risk lung nodules
2024
·
Siwei Wang
, Fanchen Meng
, et al.
·
Journal of Thoracic and Cardiovascular Surgery
·
5
Structural and copy number variation in the pig genome
2010
·
Haimeng Tang
, F. Li
, et al.
·
4
Characterizing the molecular and clinical implications of NRG1 fusions in NSCLC through integrated RNA and DNA sequencing analysis
2026
·
Yue Fan
, Chenglu Zhang
, et al.
·
European journal of medical research
·
3
Noninvasive detection and differentiation of gastric malignancy using cell-free DNA biomarkers
2025
·
Hengzhen Li
, Meng Chen
, et al.
·
Journal of Advanced Research
·
2
Mechanisms of resistance to tyrosine kinase inhibitor treatments in patients with ROS1 fusion-positive non-small cell lung cancer.
2023
·
Jialei Wang
, Xinmin Zhao
, et al.
·
Journal of Clinical Oncology
·
2
Multi-omic ctDNA-based MRD for predicting clinical outcomes in advanced NSCLC receiving chemoimmunotherapy.
2026
·
Yun Fan
, Hui Li
, et al.
·
Journal of Clinical Oncology
·
1
Multi-modal liquid biopsy integrating cfDNA fragmentomics and serum biomarkers for the differential diagnosis of ovarian tumors.
2026
·
Zhoumei Liu
, Hongying Yang
, et al.
·
Journal of Clinical Oncology
·
1
Utility of liquid biopsy for predicting cancer type and informing treatment of carcinoma with unknown primary.
2024
·
Hua Bao
, Haimeng Tang
, et al.
·
Journal of Clinical Oncology
·
1
Abstract 7408: Robust profiling of cancer-related gene fusions: Analytical validation of PANCARNA for multiple cancer types
2024
·
Haimeng Tang
, Hua Bao
, et al.
·
Cancer Research
·
1
Abstract 5047: Identifying genomic features associated with pathologic lymph node metastasis in lung adenocarcinoma patients
2024
·
Shijie Wang
, Zhiwei Zhou
, et al.
·
Cancer Research
·
1
Abstract 6412: Combination of liquid biopsy and PET/CT enhances prediction of pathological response to neoadjuvant immunochemotherapy in patients with esophageal squamous cell carcinoma
2024
·
Weixiong Yang
, Zengli Fang
, et al.
·
Cancer Research
·
1
Detecting early stage breast cancer using low-depth cell-free DNA fragmentomics: A multi-center cohort study.
2023
·
Jiaqi Liu
, Yalun Li
, et al.
·
Journal of Clinical Oncology
·
1
Abstract 5336: Dissecting the molecular mechanism of trastuzumab resistance in stage IV HER2-positive gastric cancer patients
2022
·
Qi Xu
, Jingjing Li
, et al.
·
Cancer Research
·
1
Abstract 1042: Clinical and immune correlates of response to neoadjuvant chemoimmunotherapy in dMMR/MSI-H gastric cancer
2026
·
Pengfei Yu
, Xingmao Huang
, et al.
·
Cancer Research
Abstract 1123: Machine learning classifier for cancer type identification via multi-feature genome-wide cfDNA profiling
2026
·
Yunjian Zhang
, Liang Liu
, et al.
·
Cancer Research
Abstract 1124: cfDNA fragmentomics enables sensitive early detection and tissue-of-origin prediction in gynecologic cancers
2026
·
Jin Li
, Xun Zhang
, et al.
·
Cancer Research
Abstract 2519: Characterization of BRAF fusions and their therapeutic and resistance implications in NSCLC
2026
·
Kai Wang
, Chao Yi
, et al.
·
Cancer Research
Abstract 3852: Ultrasensitive AI-driven framework for MRD detection based on multidimensional cfDNA features.
2026
·
Yunfei Shi
, Hao Zhang
, et al.
·
Cancer Research
EP.06.56 Genomic and Immune Characteristics Linked to Second-Line Combination Immunotherapy Outcome in EGFR-Mutated Advanced NSCLC
2025
·
T. Tian
, X. Zhang
, et al.
·
Journal of Thoracic Oncology
Predictive value of circulating tumor DNA detection for long-term survival in patients with advanced lung cancer undergoing chemoimmunotherapy.
2025
·
Hui Li
, Sizhe Yu
, et al.
·
Journal of Clinical Oncology
PDF
Advanced ensemble stacking model employing cfDNA fragmentation for early detection of esophageal and gastric cancer.
2025
·
Shitong Cheng
, Yusong Luo
, et al.
·
Journal of Clinical Oncology
PDF
Show more works
View as search
Works count:
67
Citation count:
71
H-index:
5
I10-index:
1
Year
Topic
Type